A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.
The current price of AstraZeneca PLC in the market is 9 064,39 ₴, with a 24-hour trading volume of 23,6B ₴. The asset's market cap is 14,05T ₴, after moving -0.39% in the last day.
Tokenized AstraZeneca PLC is trading at 4 519,73 ₴, with a tokenized market cap of 33,89M ₴ and a 24-hour trading volume of 28,02M ₴. The tokenized asset has moved -1.69% in the past 24 hours.